DorothyJMargolskeeMD

Pulmonology • Upper Montclair, NJ

Critical Care Medicine

Lecturer, Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai

Join to view full profile

Are you Dr. Margolskee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 51 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
306 Upper Mountain Ave
Upper Montclair, NJ 07043
Phone+1 973-744-5179

Fax+1 973-744-6353
Is this information wrong?

Summary

Dr. Dorothy Margolskee, MD is a pulmonologist in Upper Montclair, New Jersey. She is currently licensed to practice medicine in New Jersey. She is a Lecturer at Icahn School of Medicine at Mount Sinai.

Education & Training

University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1983
Johns Hopkins University School of MedicineClass of 1980

Certifications & Licensure

NJ State Medical License 1987 - 2015

Publications & Presentations

PubMed

2 citations
Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.
Jules I. Schwartz, Dorothy J. Margolskee, Thorir D. Bjornsson, Vanessa C. Williams, John Y.-K. Hsieh, Charles C. Lin, J. Douglas Rogers> ;British Journal of Clinical Pharmacology. 1993 Nov 1
10 citations
Urinary LTE4 excretion in antigen-provoked asthmatic patients treated with the inhaled LTD4 antagonist, L-648,051.
J. B. Rasmussen, L.-O. Eriksson, Philip Tagari, Dorothy J. Margolskee, Y. Girard, Karl-Erik Andersson> ;Allergy. 1992 Dec 1
103 citations
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Joseph N. Gaddy, Dorothy J. Margolskee, Robert K. Bush, Vanessa C. Williams, William W. Busse> ;The American Review of Respiratory Disease. 1992 Aug 1
101 citations
Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma
Jørgen Bo Rasmussen, Lars-Olof Eriksson, Dorothy J. Margolskee, Philip Tagari, Vanessa C. Williams, Karl-Erik Andersson> ;The Journal of Allergy and Clinical Immunology. 1992 Aug 1
43 citations
MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Johan Kips, Guy Joos, Inge De Lepeleire, Dorothy J. Margolskee, Agnes Buntinx, Romain Pauwels, Marcel E. Van Der Straeten> ;The American Review of Respiratory Disease. 1991 Sep 1
17 citations
Leukotriene (LT) D4 Is Involved in Antigen‐Induced Asthma: a Study with the LTD4 Receptor Antagonist, MK‐571
J. B. Rasmussen, Dorothy J. Margolskee, Lars-Olof Eriksson, Vanessa C. Williams, K. E. Andersson> ;Annals of the New York Academy of Sciences. 1991 Jul 1
12 citations
Clinical Experience with MK-571
Dorothy J. Margolskee> ;Annals of the New York Academy of Sciences. 1991 Jul 1
40 citations
Indomethacin Blocks Airway Tolerance to Repetitive Exercise but Not to Eucapnic Hyperpnea in Asthmatic Subjects
Dorothy J. Margolskee, Barbara G. Bigby, Homer A. Boushey> ;The American Review of Respiratory Disease. 1988 Apr 1
Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.
Schoors, D. F., De Smet, M., Reiss, T., Margolskee, D., Cheng, H., Larson, P., Amin, R., Somers, G.> ;Br J Clin Pharmacol. 1995 Sep
The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
Dahlén, B., Kumlin, M., Margolskee, D. J., Larsson, C., Blomqvist, H., Williams, V. C., Zetterström, O., Dahlén, S. E.> ;Eur Respir J. 1993 Jul
Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
Dahlén, B., Margolskee, D. J., Zetterström, O., Dahlén, S. E.> ;Thorax. 1993 Dec
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
Bigby, T. D., Margolskee, D., Curtis, J. L., Michael, P. F., Sheppard, D., Hadley, W. K., Hopewell, P. C.> ;Am Rev Respir Dis. 1986 Apr
Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human.
Widdicombe, J. H., Ueki, I. F., Emery, D., Margolskee, D., Yergey, J., Nadel, J. A.> ;Am J Physiol. 1989 Dec
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning, P. J., Watson, R. M., Margolskee, D. J., Williams, V. C., Schwartz, J. I., O'Byrne, P. M.> ;N Engl J Med. 1990 Dec 20
Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.
Depré, M., Margolskee, D. J., Van Hecken, A., Hsieh, J. S., Buntinx, A., De Schepper, P. J., Rogers, J. D.> ;Eur J Clin Pharmacol. 1992
Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.
Depré, M., Margolskee, D. J., Hsieh, J. Y., Van Hecken, A., Buntinx, A., De Lepeleire, I., Rogers, J. D., De Schepper, P. J.> ;Eur J Clin Pharmacol. 1992
Join now to see all